0.9689560908	phenylalanine hydroxylase
0.9676175063	duchenne muscular dystrophy
0.9674522214	ionizing radiation
0.9674253919	familial adenomatous polyposis
0.9672312056	amino acids
0.9667151373	amino acid
0.9661465108	familial mediterranean fever
0.9652609819	prader willi syndrome
0.9650961622	renal cell carcinoma
0.9636844381	metachromatic leukodystrophy
0.9635212323	pelizaeus merzbacher disease
0.9631821041	denys drash syndrome
0.9629574481	ankylosing spondylitis
0.9629230808	color vision
0.9625305560	mental retardation
0.9624451470	reading frame
0.9624263810	beta catenin
0.9620880076	wild type
0.9613019547	myotonic dystrophy
0.9607751471	adenomatous polyposis coli
0.9606313328	friedreich ataxia
0.9605669706	wiskott aldrich syndrome
0.9598875106	cell cycle
0.9596602512	autosomal dominant
0.9596490496	ataxia telangiectasia
0.9593989664	rt pcr
0.9590910808	zinc finger
0.9589657228	hearing loss
0.9588086254	kniest dysplasia
0.9574547185	gel electrophoresis
0.9570475421	van der woude syndrome
0.9560475195	ashkenazi jewish
0.9559848326	huntington disease
0.9549971215	wilson disease
0.9549625814	polymerase chain reaction
0.9541230836	diastrophic dysplasia
0.9538787073	messenger rna
0.9532805297	machado joseph disease
0.9532421270	hemolytic anemia
0.9500504346	glucose 6 phosphate dehydrogenase
0.9460358781	linkage disequilibrium
0.9456211342	von willebrand factor
0.9451046325	prostate cancer
0.9441610626	pendred syndrome
0.9440701025	ovarian cancer
0.9439849241	prenatal diagnosis
0.9424260659	tay sachs disease
0.9387031229	confidence interval
0.9385012550	breast cancer
0.9362012910	animal model
0.9356055762	uniparental disomy
0.9340900467	autosomal recessive
0.9326515127	muscular dystrophy
0.9318641954	diabetes mellitus
0.9268869927	von willebrand disease
0.9250810753	cell line
0.9246311266	norrie disease
0.9238225453	french canadian
0.9218240262	dna damage
0.9216119112	base pair
0.9200706468	tumor suppressor
0.9199291116	diabetes insipidus
0.9166228626	cholesteryl ester transfer protein
0.9149361177	beta oxidation
0.9135437650	colorectal cancer
0.9129219483	mg dl
0.9117540937	emery dreifuss muscular dystrophy
0.9115433330	missense mutations
0.9115265067	segregation distortion
0.9098977067	cell lines
0.9085302180	southern blot
0.9081208456	becker muscular dystrophy
0.9079228144	skeletal muscle
0.9045261782	fluorescence in situ hybridization
0.9015206237	fatty acids
0.8984955315	renal cell carcinomas
0.8973588527	neurohypophyseal diabetes insipidus
0.8953700213	cerebrotendinous xanthomatosis
0.8928083100	lysosomal storage
0.8915213589	lod score
0.8899534337	point mutations
0.8860499028	mps iva
0.8806276846	missense mutation
0.8803285175	15q11 q13
0.8771347808	protein kinase
0.8759113849	genotype phenotype correlations
0.8758735680	pax3 fkhr
0.8724895443	c9 deficiency
0.8673044918	wilms tumor
0.8660781819	founder effect
0.8637441392	premature termination
0.8595675585	germ line
0.8576842495	gastric cancer
0.8532589510	von hippel lindau
0.8529329536	lesch nyhan
0.8480118712	tumour suppressor
0.8464765666	canavan disease
0.8462650284	genetic counseling
0.8440609875	transgenic mice
0.8378830729	ctg repeat
0.8369661665	lesch nyhan syndrome
0.8354349005	somatic cell hybrids
0.8345073696	alpha subunit
0.8318797262	c2 deficiency
0.8261926219	tay sachs
0.8260497935	peripheral blood
0.8258875314	direct sequencing
0.8244441186	nuclear membrane
0.8242791868	acyl coa
0.8223527109	cag repeat
0.8214994887	genetic linkage
0.8214510611	stop codon
0.8205873849	coding sequence
0.8204105189	family members
0.8184266330	tumor suppressor gene
0.8110885731	adult onset
0.8030595754	highly conserved
0.8009517580	ovarian cancers
0.8002307111	skin fibroblasts
0.7975559330	linkage analysis
0.7964935990	galactose 1 phosphate
0.7949907443	fragile x syndrome
0.7925583687	von willebrand
0.7917782080	cholesteryl ester
0.7890370823	dna sequencing
0.7883619243	dna sequence
0.7876899681	prader willi
0.7853780153	frameshift mutation
0.7853777743	transcription factor
0.7817557957	single strand conformation polymorphism
0.7809980280	coding region
0.7804132262	somatic cell
0.7767800176	type ii
0.7741333225	genetic disorder
0.7661456024	proteolipid protein
0.7653433630	lod scores
0.7653057349	genomic dna
0.7646757236	nonsense mutation
0.7598445578	vlcad deficiency
0.7586604886	breast and ovarian cancer
0.7578567632	point mutation
0.7555357732	tightly linked
0.7554127496	late infantile
0.7547449964	sequence analysis
0.7544694641	clinical manifestations
0.7540043170	pelizaeus merzbacher
0.7530435378	splice donor site
0.7525502267	compound heterozygotes
0.7522849540	c3 deficiency
0.7522784604	closely linked
0.7496280862	membrane protein
0.7491866388	vwf ag
0.7439063030	splice site
0.7431974807	dominant negative
0.7418263275	g6pd deficiency
0.7397514411	amino acid substitutions
0.7378452320	cerebral ald
0.7351921066	early onset
0.7345855851	sulfate transporter
0.7339480432	carrier status
0.7337816093	growth factor
0.7332579392	coa dehydrogenase
0.7316481336	late onset
0.7298451572	donor splice site
0.7295813690	hypoxanthine guanine
0.7283151023	heteroduplex analysis
0.7258332549	hdl cholesterol
0.7244408652	ethnic groups
0.7219545374	clinical features
0.7213473201	genetic analysis
0.7188823993	g6pd mediterranean
0.7185031680	japanese and caucasian
0.7181758872	very long chain acyl
0.7158532850	splice acceptor
0.7147733725	adenomatous polyposis
0.7077414215	analysis revealed
0.7073249572	previously identified
0.7069990148	genetic heterogeneity
0.7055146281	enzymatic activity
0.7049585089	binding domain
0.7017701983	termination codon
0.7002966761	affected individuals
0.6999146888	carrier detection
0.6983626291	microsatellite markers
0.6958946055	component of complement
0.6957698286	cag repeats
0.6952815723	high density
0.6919213638	previously reported
0.6904600643	restriction fragment length
0.6872980416	very long chain fatty acids
0.6870073151	molecular analysis
0.6859572845	hereditary breast
0.6826865260	high frequency
0.6824942761	polymerase chain
0.6768751705	premature stop codon
0.6764822887	mouse model
0.6748668408	enzyme activity
0.6726069776	dm kinase
0.6724798164	hereditary hemochromatosis
0.6705299817	brca1 and brca2
0.6675886435	splice donor
0.6606527811	trinucleotide repeat
0.6576102884	single strand conformation
0.6567296789	nonsense mutations
0.6527824980	provide evidence
0.6522286431	close linkage
0.6495479627	high risk
0.6491779829	nucleotide position
0.6445417009	breast ovarian cancer
0.6437259951	c7 deficiency
0.6423364455	mutation causing
0.6381328335	protein truncation test
0.6372115049	breast ovarian
0.6339693751	unrelated families
0.6275323648	molecular genetic
0.6249998638	severe phenotype
0.6236929369	single strand
0.6235931127	long chain fatty acids
0.6231292668	breast and or ovarian cancer
0.6227140478	mutation detection
0.6224998513	truncating mutations
0.6221296018	nucleotide sequence
0.6214870001	g6pd variants
0.6185419887	human chromosome
0.6169207330	dna analysis
0.6165551012	human complement
0.6162808901	cancer susceptibility
0.6158876327	familial cases
0.6148076980	gene expression
0.6103661313	polyposis coli
0.6087052040	long chain
0.6080847701	results provide
0.6079864837	premature stop
0.6062661192	molecular basis
0.6026313839	repeat length
0.6019377476	cetp deficiency
0.6013384702	cancer risk
0.6006829918	genotype phenotype
0.5996250255	repeat expansion
0.5984641050	gene product
0.5951319587	breast and ovarian cancers
0.5940512041	age of onset
0.5935982042	germline mutation
0.5904493346	breast and ovarian
0.5870760503	dystrophin gene
0.5845302560	susceptibility gene
0.5819399999	carrier frequency
0.5807602657	southern blot analysis
0.5800911711	fap patients
0.5788772245	loss of heterozygosity
0.5780363836	dna binding
0.5771515502	sporadic breast
0.5769563708	base pair deletion
0.5764022591	mice carrying
0.5747770516	in situ hybridization
0.5747339131	bp deletion
0.5744808065	somatic mutations
0.5733958228	single nucleotide
0.5725699418	breast ovarian cancer families
0.5723564036	germline mutations
0.5707660890	brca1 or brca2
0.5688223736	population based
0.5643804536	male breast cancer
0.5638625883	amino acid substitution
0.5597618949	polymorphic markers
0.5594194500	candidate gene
0.5556487075	pcr products
0.5531369642	splice site mutation
0.5528923098	dna markers
0.5489595960	mutant alleles
0.5479717479	fluorescence in situ
0.5467488674	single base
0.5426976680	age at diagnosis
0.5417558364	protein truncation
0.5417312998	long arm of chromosome
0.5396590742	allele specific
0.5362194792	disease causing
0.5360500872	c6 deficiency
0.5350632086	protein product
0.5346809215	cancer susceptibility gene
0.5344941582	central nervous system
0.5308744537	enzyme deficiency
0.5306693342	haplotype analysis
0.5264103885	colorectal tumors
0.5253580778	restriction fragment
0.5229622407	mouse chromosome
0.5194398626	mutant mice
0.5185396052	critical region
0.5180129695	deficient mice
0.5177298288	very long chain fatty
0.5128918655	chain acyl coa
0.5114017965	affected males
0.5086692218	brca1 mutations
0.5076495018	reported previously
0.5064924650	theta = 0
0.5052610974	sscp analysis
0.5028738087	somatic mutation
0.5013739125	germ line mutations
0.5004271445	age at onset
0.4992369901	lymphoproliferative syndrome
0.4962671481	ataxin 3
0.4962501209	tumour suppressor gene
0.4957329014	genetic defect
0.4946651371	clinical phenotype
0.4935245850	dna samples
0.4915380319	maximum lod
0.4905024290	first degree relatives
0.4823942660	risk of breast cancer
0.4820030741	low levels
0.4808848233	the present study
0.4803378393	findings suggest
0.4775243446	autosomal recessive disorder
0.4753789415	linked recessive
0.4752711388	mutation analysis
0.4747119136	results suggest
0.4635514705	binding protein
0.4611607621	blood cells
0.4592024011	the c282y mutation
0.4569092061	results demonstrate
0.4565446498	cathepsin c
0.4519329739	data suggest
0.4508496457	donor splice
0.4483135181	the hexa gene
0.4476549535	de novo
0.4457120826	the pds gene
0.4447776251	japanese patients
0.4440335191	95 confidence interval
0.4436118580	previous studies
0.4407764621	ca2 +
0.4383630571	recessive disorder
0.4370863265	et al
0.4357447119	unrelated patients
0.4311796865	mutations causing
0.4308532913	wasp gene
0.4261816955	family history
0.4246796719	polymorphism analysis
0.4224751071	nervous system
0.4223823264	data provide
0.4206295505	wt1 gene
0.4186959165	hydroxylase gene
0.4171856958	phenotypic expression
0.4168017419	recessive disorder characterized by
0.4094248559	mutant allele
0.4070235052	apc mutations
0.4041740906	glucose 6 phosphate
0.3979716734	x linked adrenoleukodystrophy
0.3963226609	the wiskott aldrich
0.3908682099	the long arm
0.3890789984	untranslated region
0.3855657038	x linked
0.3778213976	increased risk
0.3637394853	donor site of
0.3510626665	renal cell
0.3488488409	general population
0.3483205987	the entire coding region
0.3425628086	the mjd1 gene
0.3379903767	year old
0.3325880606	fragment length
0.3311596721	full length
0.3284959141	x linked recessive
0.3262002442	brca1 mutation
0.3257383076	long arm of
0.3227900007	non jewish
0.3211785198	dehydrogenase deficiency
0.3195113639	these results suggest
0.3181629480	atm protein
0.3159929864	loss of function
0.3098449059	fragile x
0.3070979678	mutation in exon
0.3061622875	chromosome region
0.3046132565	locus on chromosome
0.3021415966	accounted for
0.3004886740	s phase
0.2999363549	site of intron
0.2985661998	failed to
0.2940055542	expanded allele
0.2930526275	an autosomal recessive
0.2912496385	5 phosphatase
0.2909194443	hprt gene
0.2879941924	arm of chromosome
0.2838507689	region of chromosome
0.2827117162	95 confidence
0.2778850696	inherited breast
0.2697196983	normal human
0.2696818356	exon 11
0.2644718741	na +
0.2605659773	responsible for
0.2598071640	n terminal
0.2562657600	chromosome 14
0.2542059534	by polymerase chain reaction
0.2524798569	determine whether
0.2514634004	gene encodes
0.2493417772	factor b
0.2440722801	does not
0.2439166737	caused by
0.2431986281	x chromosome
0.2430651488	z =
0.2429982858	disease gene
0.2425435250	germ line mutations in
0.2419695669	at least
0.2398082541	the entire coding
0.2391978142	an autosomal recessive disorder
0.2358653913	the pathogenesis of
0.2343697959	p =
0.2341633854	disease locus
0.2328980077	as well as
0.2283251086	the seventh
0.2273700469	previously described
0.2272050178	the wiskott aldrich syndrome
0.2269397788	n =
0.2262645578	x ald
0.2255580450	so far
0.2237946487	p 0
0.2223322425	gene deletion
0.2207107369	c to t
0.2199473367	the nucleus
0.2194798188	the entire
0.2177962983	suppressor gene
0.2175046801	rb1 gene
0.2173581337	disorder caused by
0.2162695548	exon 13
0.2159230061	greater than
0.2148334281	closely linked to
0.2144478167	these findings suggest
0.2144273121	the results of
0.2134487660	did not
0.2104126558	rather than
0.2095973367	the world
0.2093412499	a stop codon
0.2091428514	existence of
0.2091105965	the brca1 gene
0.2087569813	gene encoding
0.2057498354	a panel of
0.2044708055	the apc gene
0.2023133480	cancer cases
0.2023065122	japanese patients with
0.2009227022	3 utr
0.2008138394	exon 6
0.2006494307	pax6 gene
0.1995286454	account for
0.1992365068	consistent with
0.1986278520	leading to
0.1985667849	disorder characterized by
0.1984597262	do not
0.1976089194	t transition
0.1973635979	subset of
0.1970238932	male patients
0.1939129264	results indicate
0.1938652983	first degree
0.1924878341	chromosome 15
0.1920470178	an autosomal dominant
0.1912866166	these data suggest
0.1902447196	heterogeneity of g6pd
0.1892417085	variety of
0.1883743492	exon 7
0.1876333390	apc gene
0.1871202487	presence of
0.1867036946	based on
0.1863202047	exon 9
0.1861691254	majority of
0.1855499115	germline mutations in
0.1846795405	candidate gene for
0.1841862867	lod score of
0.1837746622	the general population
0.1833636687	3 untranslated region
0.1804330355	correlation between
0.1801698985	due to
0.1799046678	the presence
0.1796888337	able to
0.1795969538	the most common
0.1791423967	family history of
0.1785290385	the existence
0.1784634374	sequence analysis of
0.1781825364	exon 8
0.1779130484	nonsense mutation in
0.1759547383	pah gene
0.1745323348	characterized by
0.1725926422	the hd gene
0.1721250927	to determine
0.1717452911	the mjd1
0.1716967815	the ald gene
0.1707828833	followed by
0.1703637650	n repeat
0.1699261151	lead to
0.1688894018	to date
0.1680234377	a single base
0.1676324023	the majority
0.1672221077	less than
0.1669540827	vhl gene
0.1663481732	exon 5
0.1633703049	molecular analysis of
0.1619970559	the ndp gene
0.1613521683	compatible with
0.1603139373	associated with
0.1597773873	intron 9
0.1596175329	gene mutations
0.1590137712	hdl c
0.1581748586	the expanded allele
0.1562450803	a subset
0.1552353314	the lesch nyhan syndrome
0.1542048458	trinucleotide repeat in
0.1537228297	evidence for
0.1502170033	the adenomatous polyposis coli
0.1485181850	point mutations in
0.1478475757	a frameshift mutation
0.1470725109	the proteolipid protein
0.1462644930	c terminal
0.1435214467	in vitro
0.1433587009	cancer families
0.1433185347	5 end
0.1432552630	molecular basis of
0.1427129735	protein gene
0.1421074800	a missense mutation
0.1407393100	coding region of
0.1404605773	report here
0.1403935939	plp gene
0.1395863313	the atm gene
0.1386975803	or ovarian cancer
0.1386443291	the polymerase chain reaction
0.1372599340	the vhl gene
0.1356994656	leads to
0.1354452211	exon 3
0.1351709099	in order to
0.1329665146	patients with
0.1325008133	appears to
0.1309976591	most likely
0.1296822206	protein s
0.1280184638	the dmd gene
0.1277044186	the rb1 gene
0.1275313306	the wild type
0.1275307587	exon 1
0.1270811289	exon 2
0.1265715361	a point mutation
0.1243680483	theta =
0.1241669624	the same
0.1241541490	contribute to
0.1234277481	effects on
0.1233363737	ndp gene
0.1224912943	t cell
0.1223133424	these findings
0.1217858631	the pah gene
0.1198102541	the plp gene
0.1194866177	gene responsible
0.1152051164	relationship between
0.1145094205	dmd gene
0.1132343272	cancer patients
0.1110763109	more than
0.1103397150	derived from
0.1098956935	missense mutations in
0.1086725932	hd gene
0.1082173161	= 0
0.1081342482	gene mutation
0.1078694204	atm gene
0.1078587276	at theta = 0
0.1068967794	led to
0.1064480129	on chromosome
0.1064187967	by means of
0.1056416267	thought to
0.1055925615	brca1 gene
0.1043904249	chromosome 5
0.1030863938	chromosome 12
0.1026567906	transition at
0.1025897269	common mutation
0.1024527609	at nt
0.1021048320	an increased risk
0.1017133372	the gene encoding
0.1011799270	g6pd deficiency in
0.1005655469	site mutation
0.1004687884	these results
0.0999731568	increased risk of
0.0978979464	the pax6 gene
0.0973016373	required for
0.0972174167	correlated with
0.0971880396	new variants
0.0971825539	brca1 mutations in
0.0969710017	at position
0.0963986671	ctg repeat in
0.0958616572	to investigate
0.0948750008	a single
0.0945354012	located within
0.0943898066	+ 0
0.0941027047	an expanded
0.0932862757	implications for
0.0931186606	the phenylalanine hydroxylase
0.0927779356	a nonsense mutation
0.0925531999	= 6
0.0923219138	at nucleotide
0.0915265890	these observations
0.0915152300	rise to
0.0915121308	absence of
0.0914666411	an autosomal
0.0911766020	boy with
0.0911178135	the presence of
0.0909177634	to identify
0.0908693868	encoded by
0.0906621428	characterization of
0.0906541369	the mutant allele
0.0897873363	child with
0.0889167557	susceptibility to
0.0887153465	direct sequencing of
0.0886523811	these data
0.0879009377	to detect
0.0874874702	the atm protein
0.0874629429	most frequent
0.0871201793	two point
0.0868932188	to assess
0.0867583219	in addition
0.0861621977	mutations in
0.0848504716	to define
0.0846890414	effect on
0.0846198579	ald gene
0.0846141120	this study
0.0843562378	result in
0.0841048770	result from
0.0836726084	obtained from
0.0834727496	more severe
0.0814359919	ability to
0.0803598048	families with
0.0802046515	resulting in
0.0799392069	the prader willi
0.0794798434	5 kb
0.0792234912	resulting from
0.0792215142	presenting with
0.0791423714	at risk
0.0785807490	at age
0.0783793088	to screen
0.0776025609	gene responsible for
0.0773199267	an x linked
0.0771773955	a family history
0.0770205890	a total of
0.0767496363	this mutation
0.0763022180	ovarian cancer in
0.0754953946	this family
0.0754385443	homozygous for
0.0750016506	type 2
0.0746471857	a key
0.0745736946	coding for
0.0743203054	missense mutation in
0.0743055260	compared with
0.0742268325	kinase gene
0.0741175052	report on
0.0741032041	in frame
0.0722040768	of glucose 6 phosphate dehydrogenase
0.0720875002	the ataxia telangiectasia
0.0714168273	detected by
0.0713951150	further evidence
0.0696591844	6 phosphate
0.0675485177	essential for
0.0671065344	untranslated region of
0.0670087174	with adult onset
0.0666911457	heterozygous for
0.0666402995	a strong
0.0662759794	appear to
0.0662463169	mapped to
0.0659407795	screened for
0.0658398995	homozygosity for
0.0657262812	confirmed by
0.0655332463	proximal to
0.0652171922	portion of
0.0649672728	a wide
0.0649101305	substitution at
0.0643108222	linkage between
0.0640118089	determination of
0.0639858254	defined by
0.0635283378	the polymerase chain
0.0634761671	distal to
0.0631356534	detected in
0.0631087081	analysis of
0.0627149475	basis for
0.0626520274	resulted in
0.0624355886	a maximum
0.0623288488	such as
0.0621171951	a large
0.0621130250	close to
0.0620288969	3 untranslated
0.0615668710	individuals with
0.0612004565	samples from
0.0610354624	this disorder
0.0597385281	identification of
0.0596064348	in exon 4
0.0592954755	maps to
0.0589337999	loss of
0.0588463020	proportion of
0.0588431084	an animal
0.0587519762	shown to
0.0587410421	exon 4
0.0583092787	model for
0.0581909214	linked to
0.0581311567	appeared to
0.0579893424	percentage of
0.0579382598	predisposition to
0.0577995241	response to
0.0577390511	but not
0.0574120684	women with
0.0572043752	c t
0.0571066553	involved in
0.0569395730	in contrast
0.0568715067	+ 1
0.0567714383	one allele
0.0567622291	found to
0.0567439668	heterozygotes for
0.0567099297	compared to
0.0564375789	at codon
0.0555488201	one family
0.0550833273	caused by mutations in
0.0549996678	identified as
0.0547534892	a t
0.0547376317	to determine whether
0.0545334536	an inherited
0.0543715400	homologous to
0.0537886969	expression of
0.0535111157	hex a
0.0530735678	1 phosphate
0.0529433878	similar to
0.0526829937	this region
0.0525384433	in man
0.0524272776	test for
0.0520309826	novel mutations
0.0519767174	markers on
0.0516902811	patient with
0.0513198647	mechanism for
0.0507784623	consequence of
0.0506110946	a patient with
0.0505459550	different mutations
0.0505345738	one patient
0.0497924404	deficiency of
0.0497867452	role for
0.0495671394	a novel mutation
0.0493053053	this report
0.0492386330	a t patients
0.0491972318	detection of
0.0486854070	the molecular basis
0.0486157918	role in
0.0485222919	form of
0.0484050695	determined by
0.0480999677	observed in
0.0476635128	present in
0.0463042249	predicted to
0.0457646638	isolated from
0.0454686690	an early
0.0454217615	family with
0.0453933267	the central nervous system
0.0452435116	manifestation of
0.0452304187	the gene for
0.0451943114	fibroblasts from
0.0451247384	evaluation of
0.0442925574	this patient
0.0441790872	subjects with
0.0440755607	three different
0.0438323112	possibility of
0.0437714044	member of
0.0435462065	mutation in
0.0434747731	dna from
0.0431108882	ability of
0.0429396265	affected by
0.0424579886	results in
0.0423972045	found in
0.0423969403	region of
0.0421883915	screening for
0.0421881313	not only
0.0421509588	estimated to
0.0420880075	studies on
0.0419641570	linkage to
0.0418105114	identified in
0.0416195905	localized to
0.0416127500	nature of
0.0414802736	deficiency in
0.0412972888	no evidence of
0.0411420266	sequencing of
0.0411373481	set of
0.0411317272	an increased risk of
0.0410793247	fraction of
0.0409374780	a family
0.0409319179	to occur
0.0409235543	defect in
0.0406725427	the same mutation
0.0406526269	presented with
0.0405247510	levels of
0.0405159314	cases of
0.0404932120	expansion of
0.0403026688	arm of
0.0402946779	identified by
0.0401177473	at least one
0.0400923719	results from
0.0400735021	features of
0.0400341358	the proband
0.0399512464	group of
0.0398976492	ratio of
0.0396747895	the 3 untranslated region
0.0396672127	amounts of
0.0396627896	alterations in
0.0393261339	part of
0.0393053637	two unrelated
0.0391291403	this population
0.0391071025	signs of
0.0390502314	to produce
0.0390129740	known as
0.0388994472	assignment of
0.0386492964	severity of
0.0384127956	a g to
0.0383672369	diagnosis of
0.0382201733	an increased
0.0381904359	combination of
0.0380749242	role of
0.0380656281	patients from
0.0379054915	implicated in
0.0376693192	isolation of
0.0375814143	relative to
0.0375052215	a result of
0.0373637633	identical to
0.0373552598	by use of
0.0369079346	history of
0.0364741425	carriers of
0.0364558141	localization of
0.0361893626	the hypothesis
0.0361016174	understanding of
0.0359833363	level of
0.0359521079	a significant
0.0358078833	degree of
0.0357206030	region on
0.0357072631	a variety of
0.0354816394	number of
0.0353081687	related to
0.0351862837	a rare
0.0351575175	the fact
0.0351228443	heterogeneity of
0.0350665824	these studies
0.0349579021	the basis of
0.0348704583	in vivo
0.0347129624	the result of
0.0345582797	a transition
0.0345521209	also identified
0.0344113019	but also
0.0343308817	organization of
0.0342227427	the first
0.0340386968	forms of
0.0340019868	all three
0.0338235607	expressed in
0.0338013394	likely to
0.0337758655	defects in
0.0333031029	effect of
0.0332911739	the possibility
0.0332510203	the x chromosome
0.0332338809	a novel
0.0330319041	frequency of
0.0329543959	risk for
0.0329007714	increase in
0.0326756024	transmission of
0.0326452557	rate of
0.0326192792	heterogeneity in
0.0325275492	in situ
0.0324894333	case of
0.0323933806	evidence of
0.0319962591	the majority of
0.0313892726	members of
0.0310788120	together with
0.0310784924	the frequency of
0.0308888155	individuals from
0.0308653754	comparison of
0.0307697894	regulation of
0.0307075068	affected with
0.0306731369	effects of
0.0305359897	a family with
0.0304540322	located in
0.0302550731	differences in
0.0302022796	no evidence
0.0301578511	the development of
0.0300568449	occur in
0.0298937305	involvement of
0.0298526824	not detected
0.0297263591	mutations at
0.0296276067	characteristic of
0.0296134610	cells from
0.0295269803	range of
0.0294874084	mapping of
0.0294704493	the c terminal
0.0294570131	in addition to
0.0294519172	series of
0.0292911087	deleted in
0.0292111908	homologue of
0.0291380851	end of
0.0287551114	most common
0.0286202823	distribution of
0.0284906864	the last
0.0284797943	incidence of
0.0284711837	the 3 untranslated
0.0284600548	reduction in
0.0282570144	lack of
0.0281799976	inheritance of
0.0281578511	the role of
0.0280972311	the 3 untranslated region of
0.0280178813	the occurrence of
0.0279471246	pattern of
0.0278245246	position of
0.0278234654	occurred in
0.0277834808	regions of
0.0277771844	prevalence of
0.0277698445	structure of
0.0277244135	spectrum of
0.0274386202	corresponding to
0.0274234923	analyzed for
0.0274084042	in contrast to
0.0273342148	the size of
0.0273256430	in association with
0.0271366184	seen in
0.0271165960	properties of
0.0271054099	a few
0.0268493663	the age of
0.0268142188	example of
0.0268007033	amplification of
0.0267910325	half of
0.0264916314	a new
0.0264134849	risk of
0.0263745385	a transition at
0.0263375061	no other
0.0263118173	accumulation of
0.0262519101	age at
0.0261583314	mutated in
0.0260930855	in response to
0.0260902255	the identification of
0.0259589327	the location of
0.0258313061	families from
0.0257763684	none of
0.0256254320	a member of
0.0254898596	examination of
0.0254498439	mutation at
0.0254003097	abnormalities in
0.0253656311	a number of
0.0251217278	types of
0.0251072008	inactivation of
0.0248417764	onset of
0.0247565426	a role for
0.0246969272	in exon 3
0.0246899028	the gene responsible for
0.0243219970	the molecular basis of
0.0239443103	association with
0.0238129320	a subset of
0.0237910504	change in
0.0237690512	a frameshift
0.0237501942	used to
0.0237257890	genes for
0.0235885552	a mutation in
0.0234285283	mutations within
0.0231478164	domains of
0.0231058932	a family history of
0.0230773191	at theta
0.0229701767	percent of
0.0226019227	duplication of
0.0224210596	basis of
0.0217884849	development of
0.0217140630	the risk of
0.0216105653	cause of
0.0214134849	domain of
0.0213153643	the level of
0.0210713138	the expression of
0.0208617334	as well
0.0207648855	known to
0.0206422181	changes in
0.0205932242	use of
0.0204586535	location of
0.0204528927	the absence of
0.0203428308	reported in
0.0203103018	characteristics of
0.0202847840	component of
0.0201795728	function of
0.0201429786	a candidate
0.0200054704	occurrence of
0.0199352240	map of
0.0197061146	a role in
0.0195149449	to carry
0.0192616701	the number of
0.0190892564	the diagnosis of
0.0189941929	formation of
0.0189854004	t mutation
0.0188479865	the effects of
0.0188029932	manifestations of
0.0187870000	locus on
0.0187078621	different from
0.0186098930	a deficiency of
0.0184431477	means of
0.0183176276	the loss of
0.0181716429	the regulation of
0.0181398711	the substitution of
0.0180893217	the function of
0.0176176052	a child
0.0175954053	a region of
0.0174842115	at onset
0.0173372583	contrast to
0.0171982454	score of
0.0169573506	substitution of
0.0169573506	site of
0.0166099566	the formation of
0.0163970338	result of
0.0159138723	size of
0.0148581949	a stop
0.0146434739	described in
0.0141313333	transition in
0.0139240494	the most
0.0121223091	an x
